HIV testing is the necessary first step in reducing infection and interrupting transmission; without it, any efforts at diagnosis and appropriate treatment are severely impaired. But testing acceptance in particular populations has been and remains especially low.
In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania analyzes the current literature reporting on the strategies to reach these at high-risk people.
Fellow in Infectious Diseases
Division of Infectious Diseases
Department of Medicine
University of Pennsylvania Perelman School of Medicine
Associate Professor of Medicine, Physiology, Pharmacology & Therapeutics
Johns Hopkins School of Medicine
Baltimore, MD
(she/her/hers)
Associate Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, CA
(he/him/his)
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: July 9, 2020
Expiration date: July 8, 2022